Role of C9orf140 in the promotion of colorectal cancer progression and mechanisms of its upregulation via activation of STAT5, β-catenin and EZH2

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1389-1398

  Weng, Yu Rong ^a   Yu, Ya Nan ^a   Ren, Lin Lin ^a,b   Cui, Yun ^a   Lu, You Yong ^c   Chen, Hao Yan ^a   Ma, Xiong ^a   Qin, Wen Xin ^a   Cao, Weibiao ^d   Hong, Jie ^a   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING HOSPITAL   (China)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BETA CATENIN; C9ORF140 PROTEIN; DNA FRAGMENT; GENOMIC DNA; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NERVE CELL ADHESION MOLECULE; PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; CELL CYCLE PROTEIN; EZH2 PROTEIN, HUMAN; P42.3 PROTEIN, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BIOLOGICAL ACTIVITY; BRDU ASSAY; CANCER SURVIVAL; CCK 8 ASSAY; CELL INVASION; CELL INVASION ASSAY; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSWELL CELL INVASION ASSAY; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; WOUND CLOSURE; WOUND HEALING; AGED; ANIMAL; BINDING SITE; CANCER STAGING; CHEMISTRY; COLORECTAL TUMOR; DISEASE COURSE; DISEASE MODEL; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MOLECULAR GENETICS; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN BINDING; TUMOR CELL LINE; XENOGRAFT;

ADULT; AGED; ANIMALS; BASE SEQUENCE; BETA CATENIN; BINDING SITES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84905407903     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu057     Document Type: Article

References (26)

1. Bates, R.C. et al. (2005) The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther., 4, 365-370.
2. Markowitz, S.D. et al. (2002) Focus on colon cancer. Cancer Cell, 1, 233-236.
3. Xu, X. et al. (2007) Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene, 26, 7371-7379.
4. Mao, L. et al. (2012) Cell cycle-dependent expression of p42.3 promotes mitotic progression in malignant transformed cells. Mol Carcinog. doi:10.1002/mc.21982 [Epub ahead of print].
5. Cui, Y. et al. (2011) MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One, 6, e25872.
6. Jung, Y. et al. (2011) Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data. Clin. Cancer Res., 17, 700-709.
7. Zhang, J. et al. (2012) p42.3 gene expression in gastric cancer cell and its protein regulatory network analysis. Theor. Biol. Med. Model., 9, 53.
8. Takeuchi, H. et al. (2003) c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin. Cancer Res., 9, 1480-1488.
9. Kato, T. et al. (2007) Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer. Clin. Cancer Res., 13(2 Pt 1), 434-442.
10. Xiong, H. et al. (2012) Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J. Biol. Chem., 287, 5819-5832.
11. Samuels, Y. et al. (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell, 7, 561-573.
12. Fujii, S. et al. (2011) MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes. Oncogene, 30, 4118-4128.
13. Shi, B. et al. (2007) Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol. Cell. Biol., 27, 5105-5119.
14. Velichutina, I. et al. (2010) EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood, 116, 5247-5255.
15. Margolin, D.A. et al. (2011) Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1a/CXCR4 paracrine signaling. Neoplasia, 13, 874-886.
16. Chen, H.Y. et al. (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res., 72, 3631-3641.
17. Tao, Y.M. et al. (2013) BTB/POZ domain-containing protein 7: epithelialmesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma. Hepatology, 57, 2326-2337.
18. Taylor, M.A. et al. (2013) TGF-β upregulates miR-181a expression to promote breast cancer metastasis. J. Clin. Invest., 123, 150-163.
19. Zhang, L. et al. (2013) Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis, 34, 577-586.
20. Cavallaro, U. et al. (2006) Endothelial cadherins and tumor angiogenesis. Exp. Cell Res., 312, 659-667.
21. Blaschuk, O.W. et al. (2009) Cadherins as novel targets for anti-cancer therapy. Eur. J. Pharmacol., 625, 195-198.
22. Jeanes, A. et al. (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene, 27, 6920-6929.
23. Makrilia, N. et al. (2009) Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest., 27, 1023-1037.
24. Paschos, K.A. et al. (2009) The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell. Signal., 21, 665-674.
25. Thiery, J.P. et al. (2009) Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871-890.
26. Jung, H.Y. et al. (2013) PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation. Mol. Cell, 52, 193-205.